Publication Name	World Journal of Virology
Manuscript ID	79036
Country	India

Received	2022-07-29 13:24
Peer-Review Started	2022-07-29 13:26
To Make the First Decision
Return for Revision	2022-08-22 01:15
Revised	2022-08-22 10:27
Second Decision	2022-08-30 03:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-08-31 20:11
Articles in Press	2022-08-31 20:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-09-16 05:51
Publish the Manuscript Online	2022-09-24 10:56

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Critical Care Medicine
Manuscript Type	Minireviews
Article Title	Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview
Manuscript Source	Invited Manuscript
All Author List	Deven Juneja, Anish Gupta, Sahil Kataria and Omender Singh
Funding Agency and Grant Number
Corresponding Author	Deven Juneja, DNB, FCCP, MBBS, Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, Saket, 1 Press Enclave Road, New Delhi 110017, India. devenjuneja@gmail.com
Key Words	Ascorbic acid; COVID-19; SARS-CoV-2; Vitamin C
Core Tip	Vitamin C has several biochemical effects including anti-oxidant, anti-inflammatory, immuno-modulatory, and anti-viral properties which could make it a possible low-risk, add on to the current therapeutic options for managing coronavirus disease 2019 (COVID-19) patients. As it is a water-soluble vitamin, even high doses have been shown to be safe and only rarely, complications have been reported. In the last couple of years, many case series, observational studies and even randomised control trials have been conducted to evaluate the role of vitamin C in COVID-19, but have shown conflicting results. Hence, as per the current clinical evidence, the role of vitamin C remains ambiguous and it cannot be recommended as a part of routine therapeutic regimen for managing COVID-19 patients.
Publish Date	2022-09-24 10:56
Citation	Juneja D, Gupta A, Kataria S, Singh O. Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview. World J Virol 2022; 11(5): 300-309
URL	https://www.wjgnet.com/2220-3249/full/v11/i5/300.htm
DOI	https://dx.doi.org/10.5501/wjv.v11.i5.300

Full Article (PDF)	WJV-11-300.pdf
Full Article (Word)	WJV-11-300.docx
Manuscript File	79036_Auto_Edited-LS.docx
Answering Reviewers	79036-Answering reviewers.pdf
Audio Core Tip	79036-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	79036-Conflict-of-interest statement.pdf
Copyright License Agreement	79036-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	79036-Language certificate.pdf
Peer-review Report	79036-Peer-review(s).pdf
Scientific Misconduct Check	79036-Bing-Chen YL-2.png
Scientific Editor Work List	79036-Scientific editor work list.pdf